Business Wire

NY-DELOS

Share
Welcome Home to Wellness: Delos Launches World’s First Residential Wellness Technology Platform

Delos , the pioneer of wellness real estate and founder of the WELL Building Standard™, announced today the launch of the DARWIN Home Wellness Intelligence platform — a groundbreaking offering designed to enhance health outcomes in the home and mitigate harmful indoor environmental concerns, utilizing Delos’ proprietary wellness algorithms and sensor technologies, to create spaces that help reduce stress, improve sleep quality, increase performance and enhance overall well-being.

“Despite most of human history spent outside, we now spend nearly 90% of our time indoors, and yet rarely focus on the impact the indoor environment can have on our health and well-being. Through extensive scientific research and real-world testing, we discovered that we can mitigate environmental triggers within our homes to enhance both physical and emotional well-being,” said Delos Chief Executive Officer and Founder Paul Scialla. “Delos’ DARWIN platform incorporates health and wellness features and technologies into the home to bring the benefits of natural outdoor conditions inside. We are excited to work with our global partners to introduce a new era of wellness technology into homes.”

Backed by over seven years of research, the DARWIN Home Wellness Intelligence platform focuses on four main components: air filtration, water purification, circadian lighting and comfort-focused technologies, all of which simulate the natural outdoor condition. Powered by Delos’ proprietary cloud-based algorithms, the dynamic platform interacts with an ecosystem of Delos approved products and solutions to bring wellness intelligence into the connected home environment. DARWIN is flexible and accessible, launching across all segments of the housing market, from mass market to luxury.

Delos is partnering with premier dealers, installers, builders and other stakeholders across the globe to integrate the DARWIN Home Wellness Intelligence platform into residences:

  • HTSA Network: Delos is training professionals throughout the United States to become accredited DARWIN dealers and installers.
  • Simonds Homes: Simonds, a leading volume home builder in Australia, will include DARWIN as part of its base package in all new homes in the state of Victoria beginning this month, setting a new baseline for market rate housing.
  • KB Home: Delos is a title sponsor for the KB “Home of Future”, scheduled to be unveiled at the 2019 Consumer Electronics Show in Las Vegas. DARWIN will be featured as the home’s wellness technology platform.
  • Lateral Estate: Lateral, a preeminent Australian real estate developer, has announced DARWIN as a standard offering in all of its multi-family residences at Parc Blakehurst in Sydney.
  • 1371 Summitridge Drive, 521 North Cannon Drive: As part of a broad national roll out in luxury housing, these luxury single family homes in Beverly Hills, California incorporate the comprehensive home wellness platform, making them the first luxury residences to be powered by DARWIN. DARWIN is currently being commissioned by many of the most sought after newly constructed luxury homes in the United States.

“For years, the value proposition of smart technology in the home has been elusive for the masses,” said Delos Chief Technology Officer Jim Hunter. “These technologies have primarily focused on security, energy, convenience and entertainment. However, it is the health and well-being of the ones we love that is most valuable. Born out of extensive research, DARWIN is the delivery platform for our wellness algorithms that helps improve the environmental conditions where we live, work, sleep and play."

Delos has fostered leading research collaborations with the Cleveland Clinic, Mayo Clinic, a board of doctors from the Columbia University Medical Center and architects, scientists and wellness thought leaders to introduce wellness standards, programs and solutions into the built environment. Delos established the Well Living Lab™ in collaboration with Mayo Clinic — the world’s first lab committed to researching the real-world impacts of the indoor environment on human health and performance. Delos’ wellness technologies and solutions, along with the International WELL Building Institute’s WELL Building Standard, have seen broad adoption of wellness real estate programs across the commercial real estate market, with nearly 1,000 projects in 35 countries. Building upon the substantial success in the commercial sector, the launch of the DARWIN Home Wellness Intelligence platform marks the first expansion of Delos’ offerings to the residential smart-home market.

“Our home environment has a profound impact on our health, well-being and happiness. As the pioneer of wellness real estate and the founder of the WELL Building Standard, the introduction of the DARWIN Home Wellness Intelligence platform is a natural extension of Delos’ leading science and research and makes improved health, well-being and happiness available to all," said Deepak Chopra (Delos Advisory Board Member).

About Delos

Delos is a wellness real estate and technology company that is transforming the lives of people around the world by creating residential and commercial spaces designed to improve health, well-being and performance. Informed by seven years of research and rigorous analysis of environmental health impacts on people, Delos and its affiliates offer an array of innovative technology, consulting and design solutions for residential and commercial spaces. Delos’ wholly-owned subsidiary, the International WELL Building Institute pbc, delivers the WELL Building Standard™, the premier standard for buildings, interior spaces and communities seeking to implement, validate and measure features that support and advance human health and wellness. Delos’ advisory board is comprised of leading professionals across real estate, government policy, medicine and sustainability, including renowned wellness luminary Deepak Chopra and sustainability advocate Leonardo DiCaprio. For more information about Delos, please visit www.delos.com .

Contact:

Weber Shandwick for Delos Amelise Lane, 212-546-7830 alane@webershandwick.com

Link:

ClickThru

Social Media:

https://www.facebook.com/delosliving

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 07:00:00 CEST | Press release

- First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synovial health improvement via contrast-enhanced MRI - Topline results expected in the second half of 2026 4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P

Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 19:06:00 CEST | Press release

With Qi2.2 certification, Belkin reinforces its commitment to quality, safety, and performance for the next generation of wireless charging Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The comp

Cessna Grand Caravan EX to Feature New Executive Interior Options, Expanding Opportunities for Elevated Missions15.7.2025 18:05:00 CEST | Press release

The legendary Cessna Grand Caravan EX will now feature three new executive interior schemes for customers to select when designing their aircraft cabin. The Lunar, Obsidian and Saddle Sport interiors join the existing Canyon and Savanna schemes, providing a broader range of standard choices. The new interior options are available to customers starting this month and allow them to further tailor the interior of their aircraft based on their personal preference or mission. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715021096/en/ Cessna Grand Caravan EX to feature new executive interior options, expanding opportunities for elevated missions (Photo Credit: Textron Aviation) The Cessna Grand Caravan EX is designed and manufactured by Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company. Premium versions of each of the new interiors are also available, featuring quilted seat stitching and plush carpet, providing an elev

7 Million Tokens Sells Out in less than One Hour—$MBG Token Pre-Sale Shatters Expectations15.7.2025 17:27:00 CEST | Press release

MultiBank Group, the world’s largest and most regulated financial derivatives institution, has set a new benchmark in digital asset launches. The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715055611/en/ The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. Commenting on the success of the Pre-Sale, Naser Taher, Founder and Chairman of MultiBank Group, said: “The sell-out of our initial $MBG Token offering in less than one hour is a decisive validation of our vision. In a market saturated with speculation, the response we received confirms that institutional-grade transparency, regulatory integrity, and asset-backed value are what investors are now demanding. $MBG is here for the long term, reflecting t

First Patient Enrolled in National Cancer Institute’s Vanguard Study Evaluating Guardant Health’s Shield Multi-Cancer Detection Test15.7.2025 17:01:00 CEST | Press release

Study addressing feasibility of using multi-cancer detection tests in future trials aims to enroll up to 24,000 participantsShield MCD reviewed by FDA as part of NCI’s investigational device exemption (IDE) Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that patient enrollment has begun in the National Cancer Institute (NCI)’s Vanguard Study to evaluate emerging multi-cancer detection (MCD) technology. Guardant’s Shield™ MCD test was selected for use in the four-year study, which aims to enroll up to 24,000 patients and evaluate the use of MCD tests—blood tests that can screen for several types of cancer simultaneously—in future randomized controlled trials. Guardant’s Shield MCD test was chosen for the study based on the overall performance of its Shield platform in detecting 10 cancer types, including lung, breast, colorectal, prostate, bladder, ovarian, pancreatic, esophageal, liver and gastric. The data were presented at the 2025 American

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye